A 76-neonate randomized trial compared initial heparin doses during CPB. Higher initial dosing improved ACT response and a thrombin-generation marker, but clinical benefit and
This systematic review and meta-analysis of 11 studies (958 ECMO patients) compared reduced-intensity or no heparin anticoagulation with standard heparin strategies. Low/no heparin significantly
PerfusionGPT AssistantEducation · Research · Global cardiac care
Educational information only. Follow your institution’s clinical protocols. Please do not share patient information. Document search is being connected.
This site is protected by reCAPTCHA.
IPA COMMUNITY POLL
What is the biggest challenge facing your perfusion team today?